Ectopic Male Breast Cancer in Suprapubic Area That Relapsed with Hematogenous Metastasis
Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with...
Saved in:
| Published in | Journal of breast cancer Vol. 24; no. 3; pp. 344 - 348 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korean Breast Cancer Society
01.06.2021
한국유방암학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1738-6756 2092-9900 |
| DOI | 10.4048/jbc.2021.24.e21 |
Cover
| Abstract | Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them.Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them. |
|---|---|
| AbstractList | Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them.Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them. Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them. Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this disease are not fully understood. Consequently, the appropriate treatment for this disease has not been established. We report on a patient with ectopic male breast cancer in the suprapubic area that relapsed with hematogenous metastasis 3 years after complete surgical resection and adjuvant treatment despite an early diagnosis. This unusual case highlights the need for new prognostic factors such as genomic profiling to predict whether ectopic male breast cancer is aggressive and to guide on the duration between follow-ups and the appropriate method for conducting them. KCI Citation Count: 0 |
| Author | Byon, Jung Hee An, Ae Ri Choi, Eun Jung Shin, Jin Yong |
| AuthorAffiliation | 2 Department of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea 3 Department of Plastic and Reconstructive Surgery, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea 1 Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea |
| AuthorAffiliation_xml | – name: 2 Department of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea – name: 1 Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea – name: 3 Department of Plastic and Reconstructive Surgery, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea |
| Author_xml | – sequence: 1 givenname: Jung Hee orcidid: 0000-0002-5139-552X surname: Byon fullname: Byon, Jung Hee organization: Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea – sequence: 2 givenname: Ae Ri orcidid: 0000-0002-6047-1627 surname: An fullname: An, Ae Ri organization: Department of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea – sequence: 3 givenname: Jin Yong orcidid: 0000-0002-9304-8868 surname: Shin fullname: Shin, Jin Yong organization: Department of Plastic and Reconstructive Surgery, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea – sequence: 4 givenname: Eun Jung orcidid: 0000-0002-2339-4327 surname: Choi fullname: Choi, Eun Jung organization: Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002727150$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1kc1PGzEQxa0KVALtuVcf28MGf8X2XiqlEQUkEBKkUm_WrDNLDJvdre1Q9b-vQ-DQSkiW5zDv_TRP75gc9EOPhHzibKqYsqcPjZ8KJvhUqCkK_o5MBKtFVdeMHZAJN9JW2sz0ETlO6YExraQx78mRVFxYqfmE_DzzeRiDp9fQIf0WEVKmC-g9Rhp6ercdI4zbpgjmZUeXa8j0FjsYE67o75DX9AI3kId77IdtoteYCwBSSB_IYQtdwo8v84T8-H62XFxUVzfnl4v5VeVLgFxZLRnolUKrWqZbZeoaGqxXmhlua1l-bW0jDXgtVYPGN9qCh5aZhjdtK-UJ-bLn9rF1jz64AcLzvB_cY3Tz2-Wlqy1jSpii_brXlkQbXHnsc4TOjTFsIP55dv676cO6cJ6cFTPG6h3g8wsgDr-2mLLbhOSx66DHEt-JmeJSlGeLdLaX-jikFLF1PmTIYdiRQ-c4c7sGXWnQ7Rp0QrnSYPGd_ud7Pe8tx18aAp-1 |
| CitedBy_id | crossref_primary_10_1016_j_ijscr_2025_110949 crossref_primary_10_4103_bgj_bgj_5_24 crossref_primary_10_3389_fonc_2024_1473881 |
| Cites_doi | 10.3346/jkms.2019.34.e312 10.1097/MD.0000000000019506 10.1056/NEJMoa021967 10.1016/j.clbc.2011.09.004 10.2214/AJR.13.10930 10.1155/2012/286210 10.1056/NEJMoa041588 10.1159/000501304 10.2147/OTT.S184185 10.1007/s12282-009-0098-8 10.1016/j.jaad.2012.04.034 10.1631/jzus.B1600220 10.3892/ol.2015.3602 10.4048/jbc.2017.20.4.404 10.1038/nrclinonc.2015.117 |
| ContentType | Journal Article |
| Copyright | 2021 Korean Breast Cancer Society. 2021 Korean Breast Cancer Society 2021 Korean Breast Cancer Society |
| Copyright_xml | – notice: 2021 Korean Breast Cancer Society. – notice: 2021 Korean Breast Cancer Society 2021 Korean Breast Cancer Society |
| DBID | AAYXX CITATION 7X8 5PM ACYCR |
| DOI | 10.4048/jbc.2021.24.e21 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2092-9900 |
| EndPage | 348 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_9800427 PMC8250097 10_4048_jbc_2021_24_e21 |
| GroupedDBID | --- 5-W 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK DU5 EF. GROUPED_DOAJ HYE KQ8 M48 O5R O5S PGMZT RPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c404t-8630a6d4e84f06f4799abe9d6071893071688b37ac634be7cb68acaf07b1bff33 |
| IEDL.DBID | M48 |
| ISSN | 1738-6756 |
| IngestDate | Tue Nov 21 21:07:26 EST 2023 Thu Aug 21 13:53:08 EDT 2025 Fri Jul 11 05:11:33 EDT 2025 Thu Apr 24 22:54:44 EDT 2025 Tue Jul 01 01:56:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c404t-8630a6d4e84f06f4799abe9d6071893071688b37ac634be7cb68acaf07b1bff33 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 https://ejbc.kr/DOIx.php?id=10.4048/jbc.2021.24.e21 |
| ORCID | 0000-0002-9304-8868 0000-0002-2339-4327 0000-0002-5139-552X 0000-0002-6047-1627 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4048/jbc.2021.24.e21 |
| PMID | 34128361 |
| PQID | 2541321328 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9800427 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8250097 proquest_miscellaneous_2541321328 crossref_citationtrail_10_4048_jbc_2021_24_e21 crossref_primary_10_4048_jbc_2021_24_e21 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-06-01 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: 2021-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of breast cancer |
| PublicationYear | 2021 |
| Publisher | Korean Breast Cancer Society 한국유방암학회 |
| Publisher_xml | – name: Korean Breast Cancer Society – name: 한국유방암학회 |
| References | Cheng (10.4048/jbc.2021.24.e21_ref3) 2019; 12 Jeselsohn (10.4048/jbc.2021.24.e21_ref15) 2015; 12 Paik (10.4048/jbc.2021.24.e21_ref12) 2004; 351 Zhong (10.4048/jbc.2021.24.e21_ref5) 2018; 11 Bi (10.4048/jbc.2021.24.e21_ref6) 2015; 10 Lin (10.4048/jbc.2021.24.e21_ref8) 2012; 12 Yoshida (10.4048/jbc.2021.24.e21_ref11) 2012; 67 Takeyama (10.4048/jbc.2021.24.e21_ref9) 2010; 17 Yamamura (10.4048/jbc.2021.24.e21_ref10) 2012; 2012 van de Vijver (10.4048/jbc.2021.24.e21_ref13) 2002; 347 DeFilippis (10.4048/jbc.2021.24.e21_ref1) 2014; 202 Eom (10.4048/jbc.2021.24.e21_ref2) 2017; 20 Wang (10.4048/jbc.2021.24.e21_ref4) 2017; 18 Bi (10.4048/jbc.2021.24.e21_ref7) 2020; 99 Tsyganov (10.4048/jbc.2021.24.e21_ref14) 2019; 34 |
| References_xml | – volume: 34 start-page: e312 year: 2019 ident: 10.4048/jbc.2021.24.e21_ref14 publication-title: J Korean Med Sci doi: 10.3346/jkms.2019.34.e312 – volume: 99 start-page: e19506 year: 2020 ident: 10.4048/jbc.2021.24.e21_ref7 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000019506 – volume: 347 start-page: 1999 year: 2002 ident: 10.4048/jbc.2021.24.e21_ref13 publication-title: N Engl J Med doi: 10.1056/NEJMoa021967 – volume: 12 start-page: 142 year: 2012 ident: 10.4048/jbc.2021.24.e21_ref8 publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2011.09.004 – volume: 202 start-page: 1157 year: 2014 ident: 10.4048/jbc.2021.24.e21_ref1 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.13.10930 – volume: 2012 start-page: 286210 year: 2012 ident: 10.4048/jbc.2021.24.e21_ref10 publication-title: Case Rep Med doi: 10.1155/2012/286210 – volume: 351 start-page: 2817 year: 2004 ident: 10.4048/jbc.2021.24.e21_ref12 publication-title: N Engl J Med doi: 10.1056/NEJMoa041588 – volume: 12 start-page: 494 year: 2019 ident: 10.4048/jbc.2021.24.e21_ref3 publication-title: Case Rep Oncol doi: 10.1159/000501304 – volume: 11 start-page: 6625 year: 2018 ident: 10.4048/jbc.2021.24.e21_ref5 publication-title: Onco Targets Ther doi: 10.2147/OTT.S184185 – volume: 17 start-page: 151 year: 2010 ident: 10.4048/jbc.2021.24.e21_ref9 publication-title: Breast Cancer doi: 10.1007/s12282-009-0098-8 – volume: 67 start-page: e230 year: 2012 ident: 10.4048/jbc.2021.24.e21_ref11 publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2012.04.034 – volume: 18 start-page: 70 year: 2017 ident: 10.4048/jbc.2021.24.e21_ref4 publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1600220 – volume: 10 start-page: 2495 year: 2015 ident: 10.4048/jbc.2021.24.e21_ref6 publication-title: Oncol Lett doi: 10.3892/ol.2015.3602 – volume: 20 start-page: 404 year: 2017 ident: 10.4048/jbc.2021.24.e21_ref2 publication-title: J Breast Cancer doi: 10.4048/jbc.2017.20.4.404 – volume: 12 start-page: 573 year: 2015 ident: 10.4048/jbc.2021.24.e21_ref15 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2015.117 |
| SSID | ssj0064377 |
| Score | 2.2144504 |
| Snippet | Tough ectopic male breast cancer is extremely rare, non-axillary ectopic male breast cancer is even rare. To date, the natural course and prognosis of this... |
| SourceID | nrf pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 344 |
| SubjectTerms | Case Report 일반외과학 |
| Title | Ectopic Male Breast Cancer in Suprapubic Area That Relapsed with Hematogenous Metastasis |
| URI | https://www.proquest.com/docview/2541321328 https://pubmed.ncbi.nlm.nih.gov/PMC8250097 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002727150 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Breast Cancer, 2021, 24(3), 101, pp.344-348 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA86QXwRP3F-EcUHXzraNEvbJ1GZTKG-6GBvIUlTrUo3uw70v_du7aYFBaG0D0kv6V2v-V2S_o6QsyTqMqODxAE4yhxu3cQJFTie8ZkCP7eep3EeMr4X_QG_G3aH3-mAagVOfg3tMJ_UoHjrfLx_XoDDA37tcKSdfdHIRcgg2uMdiz-Vr8CwJDASi_liSQEXqGaZVgLwcEDJouL5-U1AY4hazou0gT6beyd_DEY3G2S9RpH0sjL7Jlmy-RZZjet18m0y7JlyNM4MjeH7T69w43lJr9HABc1y-jAdFwoagAqXUEYfn1VJcVvceGITilOztI9crqOKwZXGtgQBapJNdsjgpvd43XfqHAqOgUcrnVD4rhIJtyFPXZHyIIqUtlGCtHIAVeAswlD7gTLC59oGRotQGZW6gfZ0mvr-Lmnlo9zuEaqYmyaRShHhcBAUuixiXaaDyDNaa69NOnO1SVMTjGOeizcJgQbqWYKeJepZMi5Bz21yvrhhXHFr_F31FOwgX00mkQ8br08j-VpIQP23ErqCKUPa5GRuJglOgisfKregJglRMETdcIRtEjTst2gYxTZL8ux5RrcNMTT-7bL_D-kHZA07XW0lOyStspjaIwAtpT6eBfvHs1fyC6LS6-Q |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ectopic+Male+Breast+Cancer+in+Suprapubic+Area+That+Relapsed+with+Hematogenous+Metastasis&rft.jtitle=Journal+of+breast+cancer&rft.au=Byon%2C+Jung+Hee&rft.au=An%2C+Ae+Ri&rft.au=Shin%2C+Jin+Yong&rft.au=Choi%2C+Eun+Jung&rft.date=2021-06-01&rft.issn=1738-6756&rft.volume=24&rft.issue=3&rft.spage=344&rft_id=info:doi/10.4048%2Fjbc.2021.24.e21&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6756&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6756&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6756&client=summon |